{
    "xml": "<topic id=\"PHP3544\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/teicoplanin\" basename=\"teicoplanin\" title=\"TEICOPLANIN\">\n<title>TEICOPLANIN</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_852\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/teicoplanin\">Teicoplanin</xref>\n</p>\n<data name=\"vtmid\">96014005</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_402452436\" title=\"Glycopeptide antibacterials\">Glycopeptide antibacterials</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP35315\" outputclass=\"drugAction\" rev=\"1.22\" parent=\"/drugs/teicoplanin\">\n<title>Drug action</title>\n<body>\n<section>\n<sectiondiv>\n<p>The glycopeptide antibiotic <b>teicoplanin</b> has bactericidal activity against aerobic and anaerobic Gram-positive bacteria including multi-resistant staphylococci. However, there are reports of <ph outputclass=\"organism\">\n<i>Staphylococcus aureus</i>\n</ph> with reduced susceptibility to glycopeptides and increasing reports of glycopeptide-resistant enterococci. Teicoplanin is similar to vancomycin, but has a significantly longer duration of action, allowing once daily administration after the loading dose.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35295\" outputclass=\"indicationsAndDose\" rev=\"1.63\" parent=\"/drugs/teicoplanin\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">\n<ph outputclass=\"organism\">\n<i>Clostridium difficile</i>\n</ph> infection</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>100&#8211;200&#8239;mg twice daily for 10&#8211;14 days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Serious infections caused by Gram-positive bacteria (e.g. complicated skin and soft tissue infections, pneumonia)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous injection or by intravenous infusion or by intramuscular injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight up to 70 kg)</p>\n<p>Initially 400&#8239;mg every 12&#8239;hours for 3 doses, followed by 400&#8239;mg once daily.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 70 kg and above)</p>\n<p>Initially 6&#8239;mg/kg every 12&#8239;hours for 3 doses, then 6&#8239;mg/kg once daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Streptococcal or enterococcal endocarditis (in combination with another antibacterial)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous injection or by intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 10&#8239;mg/kg every 12&#8239;hours for 3&#8211;5 doses, then 10&#8239;mg/kg once daily, subsequent doses can be given by intramuscular injection.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Bone and joint infections</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion or by intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 12&#8239;mg/kg every 12&#8239;hours for 3&#8211;5 doses, then 12&#8239;mg/kg once daily subsequent doses can be given by intramuscular injection, increased risk of fever and rash with doses of 12&#8239;mg/kg.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Surgical prophylaxis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>400&#8239;mg, to be administered up to 30 minutes before the procedure.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Surgical prophylaxis in open fractures</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>800&#8239;mg, to be administered up to 30 minutes before skeletal stabilisation and definitive soft-tissue closure.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Peritonitis associated with peritoneal dialysis (added to dialysis fluid)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intraperitoneal infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>(consult local protocol).</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"pharmacokinetics\">\n<title>Pharmacokinetics</title>\n<p>Teicoplanin should <b>not</b> be given by mouth for systemic infections because it is not absorbed significantly.</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35209\" outputclass=\"unlicensedUse\" rev=\"1.17\" parent=\"/drugs/teicoplanin\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p>Teicoplanin doses in BNF may differ from those in product literature.</p>\n</sectiondiv>\n<sectiondiv>\n<p>Not licensed for surgical prophylaxis.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35287\" outputclass=\"interactions\" rev=\"1.15\" parent=\"/drugs/teicoplanin\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (teicoplanin).</p>\n<p>If other nephrotoxic or neurotoxic drugs given, monitor renal and auditory function on prolonged administration.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35239\" outputclass=\"sideEffects\" rev=\"1.22\" parent=\"/drugs/teicoplanin\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Pruritus</ph>; <ph outputclass=\"sideEffect\">rash</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Bronchospasm</ph>; <ph outputclass=\"sideEffect\">diarrhoea</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">eosinophilia</ph>; <ph outputclass=\"sideEffect\">fever</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">leucopenia</ph>; <ph outputclass=\"sideEffect\">mild hearing loss</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">thrombocytopenia</ph>; <ph outputclass=\"sideEffect\">thrombophlebitis</ph>; <ph outputclass=\"sideEffect\">tinnitus</ph>; <ph outputclass=\"sideEffect\">vestibular disorders</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Exfoliative dermatitis</ph>; <ph outputclass=\"sideEffect\">nephrotoxicity</ph>; <ph outputclass=\"sideEffect\">renal failure</ph>; <ph outputclass=\"sideEffect\">Stevens-Johnson syndrome</ph>; <ph outputclass=\"sideEffect\">toxic epidermal necrolysis</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Nephrotoxicity</p>\n<p>Teicoplanin is associated with a lower incidence of nephrotoxicity than vancomycin.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35343\" outputclass=\"allergyAndCrossSensitivity\" rev=\"1.18\" parent=\"/drugs/teicoplanin\">\n<title>Allergy and cross-sensitivity</title>\n<body>\n<section outputclass=\"allergyAndCrossSensitivityCrossSensitivity\">\n<sectiondiv>\n<p>Caution if history of vancomycin sensitivity.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35282\" outputclass=\"pregnancy\" parent=\"/drugs/teicoplanin\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises use only if potential benefit outweighs risk.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35337\" outputclass=\"breastFeeding\" parent=\"/drugs/teicoplanin\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>No information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35267\" outputclass=\"renalImpairment\" parent=\"/drugs/teicoplanin\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Use normal dose regimen on days 1&#8211;4, then use normal maintenance dose every 48 hours if eGFR 30&#8211;80&#8239;mL/minute/1.73&#8239;m<sup>2</sup> and use normal maintenance dose every 72 hours if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"additionalMonitoringInRenalImpairment\">\n<sectiondiv>\n<p>Plasma-teicoplanin concentration should be monitored during parenteral maintenance treatment. Also monitor renal and auditory function during prolonged treatment in renal impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35207\" outputclass=\"monitoringRequirements\" parent=\"/drugs/teicoplanin\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"therapeuticDrugMonitoring\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intramuscular</ph> use or <ph outputclass=\"route\">intravenous</ph> use</p>\n<p>Plasma-teicoplanin concentration is not measured routinely because a relationship between plasma concentration and toxicity has not been established. However, the plasma-teicoplanin concentration can be used to optimise parenteral treatment in severe sepsis or burns, deep-seated staphylococcal infection (including bone and joint infection), endocarditis and in intravenous drug abusers. Pre-dose (&#8216;trough&#8217;) concentrations should be greater than 15&#8239;mg/litre (greater than 20&#8239;mg/litre in endocarditis or deep-seated infection such as bone and joint infection), but less than 60&#8239;mg/litre.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intramuscular</ph> use or <ph outputclass=\"route\">intravenous</ph> use</p>\n<p>Plasma-teicoplanin concentration should be measured in elderly patients.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Blood counts and liver and kidney function tests required.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35350\" outputclass=\"directionsForAdministration\" rev=\"1.21\" parent=\"/drugs/teicoplanin\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>\n<p>For intravenous infusion (<i>Targocid</i>\n<tm tmtype=\"reg\"/>), give intermittently in Glucose 5% <i>or</i> Sodium chloride 0.9%; reconstitute initially with water for injections provided; infuse over 30 minutes. Continuous infusion not usually recommended.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use</p>\n<p>Injection can be used to prepare solution for oral administration.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP3544-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/teicoplanin\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: solution for injection</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75311\" title=\"Powder and solvent for solution for injection\" namespace=\"/drugs/teicoplanin/powder-and-solvent-for-solution-for-injection\">Powder and solvent for solution for injection</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78125\" namespace=\"/treatment-summaries/gastro-intestinal-system-infections-bacterial\" title=\"Gastro-intestinal system infections, bacterial\" count=\"1\" rel=\"backlink\">Gastro-intestinal system infections, bacterial</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78210\" namespace=\"/treatment-summaries/antibacterials-use-for-prophylaxis\" title=\"Antibacterials, use for prophylaxis\" count=\"16\" rel=\"backlink\">Antibacterials, use for prophylaxis</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78289\" namespace=\"/treatment-summaries/mrsa\" title=\"MRSA\" count=\"1\" rel=\"backlink\">MRSA</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78436\" namespace=\"/treatment-summaries/skin-infections-bacterial\" title=\"Skin infections, bacterial\" count=\"1\" rel=\"backlink\">Skin infections, bacterial</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78484\" namespace=\"/treatment-summaries/musculoskeletal-system-infections-bacterial\" title=\"Musculoskeletal system infections, bacterial\" count=\"2\" rel=\"backlink\">Musculoskeletal system infections, bacterial</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78491\" namespace=\"/treatment-summaries/blood-infections-bacterial\" title=\"Blood infections, bacterial\" count=\"3\" rel=\"backlink\">Blood infections, bacterial</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78577\" namespace=\"/treatment-summaries/respiratory-system-infections-bacterial\" title=\"Respiratory system infections, bacterial\" count=\"4\" rel=\"backlink\">Respiratory system infections, bacterial</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78592\" namespace=\"/treatment-summaries/cardiovascular-system-infections-bacterial\" title=\"Cardiovascular system infections, bacterial\" count=\"3\" rel=\"backlink\">Cardiovascular system infections, bacterial</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_852\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/teicoplanin\" title=\"Teicoplanin\" count=\"1\" rel=\"link\">Teicoplanin</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75311\" namespace=\"/drugs/teicoplanin/powder-and-solvent-for-solution-for-injection\" title=\"Powder and solvent for solution for injection\" count=\"1\" rel=\"link\">Powder and solvent for solution for injection</xref>\n</links>\n</topic>",
    "id": "PHP3544",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/teicoplanin",
    "basename": "teicoplanin",
    "title": "TEICOPLANIN",
    "interactants": [
        {
            "id": "bnf_int_852",
            "label": "Teicoplanin"
        }
    ],
    "vtmid": "96014005",
    "drugClassification": [
        "Glycopeptide antibacterials"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "drugAction": {
        "drugAction": [
            {
                "type": "drugAction",
                "textContent": "The glycopeptide antibiotic teicoplanin has bactericidal activity against aerobic and anaerobic Gram-positive bacteria including multi-resistant staphylococci. However, there are reports of Staphylococcus aureus with reduced susceptibility to glycopeptides and increasing reports of glycopeptide-resistant enterococci. Teicoplanin is similar to vancomycin, but has a significantly longer duration of action, allowing once daily administration after the loading dose.",
                "html": "<p>The glycopeptide antibiotic <b>teicoplanin</b> has bactericidal activity against aerobic and anaerobic Gram-positive bacteria including multi-resistant staphylococci. However, there are reports of <ph outputclass=\"organism\">\n<i>Staphylococcus aureus</i>\n</ph> with reduced susceptibility to glycopeptides and increasing reports of glycopeptide-resistant enterococci. Teicoplanin is similar to vancomycin, but has a significantly longer duration of action, allowing once daily administration after the loading dose.</p>"
            }
        ]
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Clostridium difficile infection",
                        "html": "<ph outputclass=\"organism\"> <i>Clostridium difficile</i> </ph> infection",
                        "organism": "Clostridium difficile"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth",
                    "organism": "Clostridium difficile"
                },
                "adult": [
                    {
                        "textContent": "100&#8211;200 mg twice daily for 10&#8211;14 days.",
                        "html": "<p>100&#8211;200&#8239;mg twice daily for 10&#8211;14 days.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Serious infections caused by Gram-positive bacteria (e.g. complicated skin and soft tissue infections, pneumonia)",
                        "html": "Serious infections caused by Gram-positive bacteria (e.g. complicated skin and soft tissue infections, pneumonia)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection or intravenous infusion or intramuscular injection"
                    ],
                    "textContent": "By intravenous injection or by intravenous infusion or by intramuscular injection",
                    "html": "By intravenous injection or by intravenous infusion or by intramuscular injection"
                },
                "adult": [
                    {
                        "textContent": "Initially 400 mg every 12 hours for 3 doses, followed by 400 mg once daily.",
                        "html": "<p>Initially 400&#8239;mg every 12&#8239;hours for 3 doses, followed by 400&#8239;mg once daily.</p>",
                        "ageGroup": "(body-weight up to 70 kg)"
                    },
                    {
                        "textContent": "Initially 6 mg/kg every 12 hours for 3 doses, then 6 mg/kg once daily.",
                        "html": "<p>Initially 6&#8239;mg/kg every 12&#8239;hours for 3 doses, then 6&#8239;mg/kg once daily.</p>",
                        "ageGroup": "(body-weight 70 kg and above)"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Streptococcal or enterococcal endocarditis (in combination with another antibacterial)",
                        "html": "Streptococcal or enterococcal endocarditis (in combination with another antibacterial)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection or intravenous infusion"
                    ],
                    "textContent": "By intravenous injection or by intravenous infusion",
                    "html": "By intravenous injection or by intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "Initially 10 mg/kg every 12 hours for 3&#8211;5 doses, then 10 mg/kg once daily, subsequent doses can be given by intramuscular injection.",
                        "html": "<p>Initially 10&#8239;mg/kg every 12&#8239;hours for 3&#8211;5 doses, then 10&#8239;mg/kg once daily, subsequent doses can be given by intramuscular injection.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Bone and joint infections",
                        "html": "Bone and joint infections"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion or intravenous injection"
                    ],
                    "textContent": "By intravenous infusion or by intravenous injection",
                    "html": "By intravenous infusion or by intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "Initially 12 mg/kg every 12 hours for 3&#8211;5 doses, then 12 mg/kg once daily subsequent doses can be given by intramuscular injection, increased risk of fever and rash with doses of 12 mg/kg.",
                        "html": "<p>Initially 12&#8239;mg/kg every 12&#8239;hours for 3&#8211;5 doses, then 12&#8239;mg/kg once daily subsequent doses can be given by intramuscular injection, increased risk of fever and rash with doses of 12&#8239;mg/kg.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Surgical prophylaxis",
                        "html": "Surgical prophylaxis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection"
                    ],
                    "textContent": "By intravenous injection",
                    "html": "By intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "400 mg, to be administered up to 30 minutes before the procedure.",
                        "html": "<p>400&#8239;mg, to be administered up to 30 minutes before the procedure.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Surgical prophylaxis in open fractures",
                        "html": "Surgical prophylaxis in open fractures"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion"
                    ],
                    "textContent": "By intravenous infusion",
                    "html": "By intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "800 mg, to be administered up to 30 minutes before skeletal stabilisation and definitive soft-tissue closure.",
                        "html": "<p>800&#8239;mg, to be administered up to 30 minutes before skeletal stabilisation and definitive soft-tissue closure.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Peritonitis associated with peritoneal dialysis (added to dialysis fluid)",
                        "html": "Peritonitis associated with peritoneal dialysis (added to dialysis fluid)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intraperitoneal infusion"
                    ],
                    "textContent": "By intraperitoneal infusion",
                    "html": "By intraperitoneal infusion"
                },
                "adult": [
                    {
                        "textContent": "(consult local protocol).",
                        "html": "<p>(consult local protocol).</p>"
                    }
                ]
            }
        ],
        "pharmacokinetics": [
            {
                "type": "pharmacokinetics",
                "title": "Pharmacokinetics",
                "textContent": "Teicoplanin should not be given by mouth for systemic infections because it is not absorbed significantly.",
                "html": "<p>Teicoplanin should <b>not</b> be given by mouth for systemic infections because it is not absorbed significantly.</p>"
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "textContent": "Teicoplanin doses in BNF may differ from those in product literature.",
                "html": "<p>Teicoplanin doses in BNF may differ from those in product literature.</p>"
            },
            {
                "type": "unlicensedUse",
                "textContent": "Not licensed for surgical prophylaxis.",
                "html": "<p>Not licensed for surgical prophylaxis.</p>"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (teicoplanin).\n\nIf other nephrotoxic or neurotoxic drugs given, monitor renal and auditory function on prolonged administration.",
                "html": "<p>Appendix 1 (teicoplanin).</p><p>If other nephrotoxic or neurotoxic drugs given, monitor renal and auditory function on prolonged administration.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Pruritus",
                        "html": "Pruritus",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Bronchospasm",
                        "html": "Bronchospasm",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "diarrhoea",
                        "html": "diarrhoea",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "eosinophilia",
                        "html": "eosinophilia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "fever",
                        "html": "fever",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "leucopenia",
                        "html": "leucopenia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "mild hearing loss",
                        "html": "mild hearing loss",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "thrombocytopenia",
                        "html": "thrombocytopenia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "thrombophlebitis",
                        "html": "thrombophlebitis",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "tinnitus",
                        "html": "tinnitus",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "vestibular disorders",
                        "html": "vestibular disorders",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Exfoliative dermatitis",
                        "html": "Exfoliative dermatitis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nephrotoxicity",
                        "html": "nephrotoxicity",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "renal failure",
                        "html": "renal failure",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "Stevens-Johnson syndrome",
                        "html": "Stevens-Johnson syndrome",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "toxic epidermal necrolysis",
                        "html": "toxic epidermal necrolysis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "title": "Nephrotoxicity",
                "textContent": "Teicoplanin is associated with a lower incidence of nephrotoxicity than vancomycin.",
                "html": "<p>Teicoplanin is associated with a lower incidence of nephrotoxicity than vancomycin.</p>"
            }
        ]
    },
    "allergyAndCrossSensitivity": {
        "crossSensitivity": [
            {
                "type": "crossSensitivity",
                "textContent": "Caution if history of vancomycin sensitivity.",
                "html": "<p>Caution if history of vancomycin sensitivity.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises use only if potential benefit outweighs risk.",
                "html": "<p>Manufacturer advises use only if potential benefit outweighs risk.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "No information available.",
                "html": "<p>No information available.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Use normal dose regimen on days 1&#8211;4, then use normal maintenance dose every 48 hours if eGFR 30&#8211;80 mL/minute/1.73 m2 and use normal maintenance dose every 72 hours if eGFR less than 30 mL/minute/1.73 m2.",
                "html": "<p>Use normal dose regimen on days 1&#8211;4, then use normal maintenance dose every 48 hours if eGFR 30&#8211;80&#8239;mL/minute/1.73&#8239;m<sup>2</sup> and use normal maintenance dose every 72 hours if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>"
            }
        ],
        "additionalMonitoring": [
            {
                "type": "additionalMonitoring",
                "textContent": "Plasma-teicoplanin concentration should be monitored during parenteral maintenance treatment. Also monitor renal and auditory function during prolonged treatment in renal impairment.",
                "html": "<p>Plasma-teicoplanin concentration should be monitored during parenteral maintenance treatment. Also monitor renal and auditory function during prolonged treatment in renal impairment.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "therapeuticDrugMonitoring": [
            {
                "type": "therapeuticDrugMonitoring",
                "specificity": {
                    "textContent": "With intramuscular use or intravenous use",
                    "html": "With <ph outputclass=\"route\">intramuscular</ph> use or <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intramuscular",
                        "intravenous"
                    ]
                },
                "textContent": "Plasma-teicoplanin concentration is not measured routinely because a relationship between plasma concentration and toxicity has not been established. However, the plasma-teicoplanin concentration can be used to optimise parenteral treatment in severe sepsis or burns, deep-seated staphylococcal infection (including bone and joint infection), endocarditis and in intravenous drug abusers. Pre-dose (&#8216;trough&#8217;) concentrations should be greater than 15 mg/litre (greater than 20 mg/litre in endocarditis or deep-seated infection such as bone and joint infection), but less than 60 mg/litre.",
                "html": "<p>Plasma-teicoplanin concentration is not measured routinely because a relationship between plasma concentration and toxicity has not been established. However, the plasma-teicoplanin concentration can be used to optimise parenteral treatment in severe sepsis or burns, deep-seated staphylococcal infection (including bone and joint infection), endocarditis and in intravenous drug abusers. Pre-dose (&#8216;trough&#8217;) concentrations should be greater than 15&#8239;mg/litre (greater than 20&#8239;mg/litre in endocarditis or deep-seated infection such as bone and joint infection), but less than 60&#8239;mg/litre.</p>"
            },
            {
                "type": "therapeuticDrugMonitoring",
                "specificity": {
                    "textContent": "With intramuscular use or intravenous use",
                    "html": "With <ph outputclass=\"route\">intramuscular</ph> use or <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intramuscular",
                        "intravenous"
                    ]
                },
                "textContent": "Plasma-teicoplanin concentration should be measured in elderly patients.",
                "html": "<p>Plasma-teicoplanin concentration should be measured in elderly patients.</p>"
            }
        ],
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Blood counts and liver and kidney function tests required.",
                "html": "<p>Blood counts and liver and kidney function tests required.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous infusion (Targocid ), give intermittently in Glucose 5% or Sodium chloride 0.9%; reconstitute initially with water for injections provided; infuse over 30 minutes. Continuous infusion not usually recommended.",
                "html": "<p>For intravenous infusion (<i>Targocid</i>\n<tm tmtype=\"reg\"/>), give intermittently in Glucose 5% <i>or</i> Sodium chloride 0.9%; reconstitute initially with water for injections provided; infuse over 30 minutes. Continuous infusion not usually recommended.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With <ph outputclass=\"route\">oral</ph> use",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "Injection can be used to prepare solution for oral administration.",
                "html": "<p>Injection can be used to prepare solution for oral administration.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "solution for injection"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75311",
                "label": "Powder and solvent for solution for injection",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78125",
                "label": "Gastro-intestinal system infections, bacterial",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78210",
                "label": "Antibacterials, use for prophylaxis",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78289",
                "label": "MRSA",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78436",
                "label": "Skin infections, bacterial",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78484",
                "label": "Musculoskeletal system infections, bacterial",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78491",
                "label": "Blood infections, bacterial",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78577",
                "label": "Respiratory system infections, bacterial",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78592",
                "label": "Cardiovascular system infections, bacterial",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_852",
                "label": "Teicoplanin",
                "type": "interaction"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75311",
                "label": "Powder and solvent for solution for injection",
                "type": "medicinalForm"
            }
        ]
    }
}